Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The studyHong JSW, Atkinson LZ, Al-Juffali N, et al. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: systematic review, meta-analysis, and rationale. Mol Psychiatry 2022;27:1339-49.To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/review-finds-little-evidence-support-gabapentinoid-use-bipolar-disorder-or-insomnia/.

Original publication

DOI

10.1136/bmj.o2576

Type

Journal article

Journal

BMJ (Clinical research ed.)

Publication Date

11/2022

Volume

379

Addresses

NIHR Centre for Engagement and Dissemination, Twickenham, UK NIHRAlerts@nihr.ac.uk.

Keywords

Humans, Sleep Initiation and Maintenance Disorders, Bipolar Disorder, Pregabalin, Gabapentin